Heavy menstrual bleeding: Understanding the options Hayley Harrison served as a consumer advocate for the Australian Commission of Safety and Quality in Health Care on the ‘Heavy menstrual bleeding clinical standard’, bringing her lived experience of the condition to the working group.
Clinical Pearl: Osteoporosis and breast cancer Bone health is of paramount importance for patients undergoing aromatase inhibitor (AI) therapy for breast cancer. While endocrine treatments improve cancer-specific outcomes, they may cause severe hypogonadism leading to accelerated bone loss.